Recent Updates on the Management of Adrenal Incidentalomas
Endocrinology and Metabolism · 31.08.2023 · 38 (4) · 373-380
DOI: 10.3803/enm.2023.1779 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.08.2023. Verfasst von Seung Shin Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Cushing Syndrome. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, Korea Health Industry Development Institute, Ministry of Health and Welfare.
Abstract (Originalsprache)
Adrenal incidentalomas represent an increasingly common clinical conundrum with significant implications for patients. The revised 2023 European Society of Endocrinology (ESE) guideline incorporates cutting-edge evidence for managing adrenal incidentalomas. This paper provides a concise review of the updated contents of the revised guideline. In the 2023 guideline, in patients without signs and symptoms of overt Cushing’s syndrome, a post-dexamethasone cortisol level above 50 nmol/L (>1.8 μg/dL) should be considered as mild autonomous cortisol secretion. Regarding the criteria of benign adrenal adenomas, a homogeneous adrenal mass with ≤10 Hounsfield units on non-contrast computed tomography requires no further follow-up, irrespective of its size. The updated guideline also discusses steroid metabolomics using tandem mass spectrometry to discriminate malignancy. It underscores the importance of high-volume surgeons performing adrenalectomy and emphasizes the pivotal role of a multidisciplinary team approach in deciding the treatment plan for indeterminate adrenal masses. The guideline advocates for more proactive surgical treatment for indeterminate adrenal masses in young patients (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Förderung
- NIEHS NIH HHS
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
Zitieren
APA
Park, S. S., & Kim, J. H. (2023). Recent Updates on the Management of Adrenal Incidentalomas. Endocrinology and Metabolism, 38(4), 373-380. https://doi.org/10.3803/enm.2023.1779
Vancouver
Park SS, Kim JH. Recent Updates on the Management of Adrenal Incidentalomas. Endocrinology and Metabolism. 2023;38(4):373-380. doi:10.3803/enm.2023.1779
BibTeX
@article{Park2023,
author = {Park, Seung Shin and Kim, Jung Hee},
title = {Recent Updates on the Management of Adrenal Incidentalomas},
journal = {Endocrinology and Metabolism},
year = {2023},
volume = {38},
number = {4},
pages = {373--380},
doi = {10.3803/enm.2023.1779}
}
EUVIMED